NYSE:RVTYLife Sciences
Is It Time To Reassess Revvity (RVTY) After Its Recent Share Price Rebound?
Wondering whether Revvity at about US$96.95 is offering fair value or a potential mispricing opportunity? This article walks through the key signals to help you frame that question clearly.
The stock has recently gained 3.2% over the last 7 days and 11.7% over the last 30 days, even though it is still down 1.2% year to date. Its 3 year and 5 year returns of 16.2% and 32.4% respectively are also in decline.
Recent coverage has focused on Revvity’s position within life sciences and...